Clinical and urodynamic criteria for antimuscarinic nonresponse in men are needed along with more quality research on treatment alternatives. The beta-3 agonist mirabegron has the most evidence for ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation ...

Antimuscarinic drugs are the first-line treatment for overactive bladder. However, traditional formulations are associated with a number of adverse effects, most notably dry mouth. A study comparing a ...

Q: In two weeks, I am supposed to get Botox injections in my bladder for an overactive bladder (OAB) and my frequent need to urinate at nighttime. Are these injections safe? Are there any bad side ...

Studies comparing propiverine hydrochloride with newer antimuscarinic agents such as solifenacin succinate for the treatment of overactive bladder (OAB) in Japanese patients have not been performed.

CLEVELAND, Ohio (March 1, 2023)—Approximately 33% of American women will experience overactive bladder syndrome (OAB), which interferes with daily activities, social functioning, and sleep quality.

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dr. Roach: In two weeks, I am supposed to get Botox injections in my bladder for an overactive bladder (OAB) and my frequent need ...

"My bladder is ruining my life," Mr. X said as he sat down on the exam table, already nervous about his first time seeing a urologist. He had considered skipping his appointment, but he simply can't ...

Medical technologies guidance 50 has been migrated to HealthTech guidance 554. The recommendations and accompanying content remain unchanged. This guidance replaces the NICE medtech innovation ...